.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Prof. Dr. Lars H. Lindner

Munich, DE

University of Munich

Chair

28/09/2023
14:00 – 15:30
Scientific session
Clinical applications & Trial
Plenary hall

Speaker

27/09/2023
14:00 – 14:30 30 Min. 0 Min.
Clinical Hyperthermia in combination with chemotherapy
27/09/2023
15:50 – 16:00 10 Min. 0 Min.
Welcome speech of the ESHO board
28/09/2023
15:00 – 15:12 10 Min. 2 Min.
Trial in progress: First-in-human phase I study of THE001 combined with regional hyperthermia in patients with locally advanced or metastatic soft tissue sarcoma
Clinical Applications & Trials
29/09/2023
13:30 – 13:48 15 Min. 3 Min.
Targeted Tumor Therapy enhanced by Hyperthermia

Further involvements

27/09/2023
P14
Hyperthermia in the treatment of high-risk soft tissue sarcomas: A systematic review
Clinical Applications & Trials
28/09/2023
12:18 – 12:30 10 Min. 2 Min.
Impact of deep learning - based body fat drift correction method on Magnetic Resonance Thermometry Performance
Technology Development in Hyperthermia (RF, Light, HIFU, etc)
28/09/2023
15:00 – 15:12 10 Min. 2 Min.
Trial in progress: First-in-human phase I study of THE001 combined with regional hyperthermia in patients with locally advanced or metastatic soft tissue sarcoma
Clinical Applications & Trials
28/09/2023
P27
Targeted delivery of chemotherapeutics via thermosensitive liposomes and mild-hyperthermia for the treatment of drug-resistant solid tumors
Hyperthermia Drug Delivery, Nanoparticles
28/09/2023
P37
Evaluation of MR thermometry reproducibility of the Sigma-30/MR Applicator
Quality Assurance, Image guidance, Thermometry, Treatment planning
29/09/2023
14:00 – 14:12 10 Min. 2 Min.
Local delivery of cisplatin using thermosensitive liposomes and MR-HIFU hyperthermia in a large animal model
Hyperthermia Drug Delivery, Nanoparticles
29/09/2023
14:36 – 14:48 10 Min. 2 Min.
A heat-activated drug-delivery platform: enhancing drug delivery with nanocarriers based on Phosphatidyl-(Oligo)-Glycerol
Hyperthermia Drug Delivery, Nanoparticles
29/09/2023
16:30 – 16:42 10 Min. 2 Min.
Correlation between invasive measured temperatures treatment outcome in high-risk soft tissue Sarcoma
Quality Assurance, Image guidance, Thermometry, Treatment planning